High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition.

Cai J, Jacob S, Kurupi R, Dalton KM, Coon C, Greninger P, Egan RK, Stein GT, Murchie E, McClanaghan J, Adachi Y, Hirade K, Dozmorov M, Glod J, Boikos SA, Ebi H, Hao H, Caponigro G, Benes CH, Faber AC
Cell Rep. 2022 Jul 26;40(4):111095. doi: 10.1016/j.celrep.2022.111095. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.